BioSpace News Archive

Business

Investor’s Corner: Q2 Pharma and Biotech Insights for Investors

As the second financial quarter of the year comes to a close, pharma and biotech companies are releasing their financial results. For more information on the top-earning companies, read on.

July 28, 2022
·
5 min read
·
Rosemary Scott
Sanofi Launches HBCU Diversity Partnership, Stays Strong in Q2 as Dupixent Thrives

Sanofi released its second quarter financial report just two days after it announced its new diversity initiative with HBCU Howard University. Plus: Up-and-coming eczema biologics to shake Dupixent’s foothold

July 28, 2022
·
3 min read
·
Tristan Manalac
Business

AVEO Oncology to Announce Second Quarter 2022 Financial Results on August 4, 2022

AVEO Oncology, a commercial stage, oncology-focused biopharmaceutical company, announced that it will report second quarter 2022 financial results on Thursday, August 4, 2022.

July 28, 2022
·
2 min read
Business

DermTech Appoints Chief Compliance Officer and SVP of Research and Development

DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics platform, has appointed two new members to its senior leadership team.

July 28, 2022
·
5 min read
Business

Pear Therapeutics to Issue Second Quarter 2022 Financial Results on Thursday, August 11, 2022

Pear Therapeutics, Inc., the leader in developing and commercializing software-based medicines called prescription digital therapeutics, announced it will issue its second quarter 2022 financial results after the close of market on Thursday, August 11, 2022.

July 28, 2022
·
2 min read
Business

CVRx Reports Second Quarter 2022 Financial and Operating ResultsSecond quarter 2022 revenue of $5.0 million, a 61% increase over prior year

CVRx, Inc. announced its financial and operating results for the second quarter of 2022.

July 28, 2022
·
11 min read
Business

SIGA Technologies to Host Business Update Call on August 4th, 2022 Following Release of Second Quarter 2022 Financial Results

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, August 4th, 2022.

July 28, 2022
·
7 min read
Business

Matinas BioPharma to Webcast Conference Call Discussing Second Quarter 2022 Financial and Operational Results on August 11, 2022

Matinas BioPharma Holdings, Inc. announced the Company will host a conference call and live audio webcast on Thursday, August 11, 2022 at 8:30 a.m. ET to discuss operational and financial results for the second quarter ended June 30, 2022.

July 28, 2022
·
4 min read
BioMidwest

VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock - July 28, 2022

VolitionRx Limited, a multi-national epigenetics company, announced that it has commenced an underwritten public offering of its common stock.

July 28, 2022
·
5 min read
Business

Sangamo Therapeutics Announces Second Quarter 2022 Conference Call and Webcast

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company has scheduled the release of its second quarter 2022 financial results after the market closes on Thursday, August 4, 2022.

July 28, 2022
·
1 min read